Existing drugs can sometimes be repurposed to treat rare diseases. But making that match can be hard — and the financial incentives are weak. Guest host Steve Levitt tries to solve the puzzle.
 
<ul>
 <li>SOURCES:
 <ul>
 <li><a href="https://faculty-directory.dartmouth.edu/christopher-snyder" rel="noopener noreferrer">Chris Snyder</a>, professor of economics at Dartmouth College.</li>
 <li><a href="https://www.med.upenn.edu/apps/faculty/index.php/g275/p8205911" rel="noopener noreferrer">David Fajgenbaum</a>, co-founder and president of Every Cure, physician-scientist at the University of Pennsylvania.</li>
 <li><a href="https://www.linkedin.com/in/heather-stone-51a94a49/" rel="noopener noreferrer">Heather Stone</a>, health science policy analyst at the Food & Drug Administration.</li>
 <li><a href="https://www.linkedin.com/in/s-chethik/" rel="noopener noreferrer">Sarrin Chethik</a>, senior policy analyst at the Market Shaping Accelerator.</li>
 </ul></li>
</ul>
 
<ul>
 <li>RESOURCES:
 <ul>
 <li><a href="https://amzn.to/40inncE" rel="noopener noreferrer">Chasing My Cure: A Doctor's Race to Turn Hope into Action; A Memoir</a>, by David Fajgenbaum (2019).</li>
 <li><a href="https://amzn.to/4tOfJEA" rel="noopener noreferrer">Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases</a>, by Michael Kremer and Rachel Glennerster (2016).</li>
 <li><a href="https://www.marketshapingaccelerator.org/" rel="noopener noreferrer">Market Shaping Accelerator</a>.</li>
 <li><a href="https://cure.ncats.io/create" rel="noopener noreferrer">CURE ID Registry</a>.</li>
 </ul></li>
</ul> Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

664. Are Thousands of Medical Cures Hiding in Plain Sight?

Freakonomics Radio

AI Chapters

AI Insights

Reviews